脂肪细胞因子基因多态性与T2DM关联性Meta分析
Association of adipocytokine gene polymorphisms with type 2 diabetes mellitus: a meta-analysis
-
摘要: 目的应用Meta分析对脂肪细胞因子中的肿瘤坏死因子α、瘦素受体和脂联素基因多态性与2型糖尿病(T2DM)关联性进行综合评价。方法应用哈代-温伯格平衡对入选文献的基因型进行遗传平衡性检验,根据异质性检验结果选用固定或随机效应模型,采用Begg's和Egger's法对发表偏倚进行量化检测,应用RevMan 5.1软件进行Meta分析。结果共50篇文献符合条件纳入研究,纳入文献无明显发表偏倚;瘦素受体SNP-668A>G与T2DM的关联性差异无统计学意义;而肿瘤坏死因子αSNP-308G>A A对G等位基因的OR(95%CI)=1.38(1.11~1.71),GA+AA对GG基因型的OR(95%CI)=1.26(1.05~1.51),差异均有统计学意义(P<0.05);脂联素SNP+45T>G G对T等位基因的OR(95%CI)=1.17(1.03~1.33),GG+TG对TT基因型的OR(95%CI)=1.16(1.01~1.34),差异均有统计学意义(P<0.05)。结论瘦素受体SNP-668A>G基因多态性与T2DM无明显关联,而肿瘤坏死因子αSNP-308G>A和脂联素SNP+45T>G可能是T2DM的危险因素。Abstract: Objective To evaluate the associations of gene polymorphisms in adipocytokines tumor necrosis factor α( TNFα),leptin receptor and adiponectin with type 2 diabetes mellitus( T2DM) using method of meta-analysis. Methods Hardy-Weinberg equilibrium( HWE) test was used to check genetic equilibrium between genotypes for the selected literature. A fixed or random effect model was used on the basis of heterogeneity. Publication bias was quantified and examined with the Begg’s and Egger’s method. The meta-analysis was performed with Review Manager 5. 1 Software. Results Fifty reports met the inclusion criteria for this meta-analysis. No significant publication bias was identified in the selected literature. There were no statistical significant results found regarding the association of leptin receptor( LEPR) single nucleotide polymorphism( SNP)-668A > G and T2DM. However,for TNFα SNP-308G > A,the odds ratioORand 95%confidence interval 95% CIfor A vs G allele and GA + AA vs GG were 1. 38( 1. 11- 1. 71) and 1. 26( 1. 05- 1. 51),respectively,with statistical significances. For adiponectin SNP + 45T > G,the OR( 95% CI) for G vs T allele and GG +TG vs TT was 1. 17( 1. 03- 1. 33) and 1. 16( 1. 01- 1. 34). Conclusion There is no significant association between the LEPR SNP-668A > G polymorphisms and risk for T2DM. However,TNFα SNP-308G > A and adiponectin SNP + 45T >G might be risk factors for type 2 diabetes mellitus.